Cancer can be precisely diagnosed using a urine test with
artificial intelligence

Prostate cancer is one of the most common cancers
among men. Patients are determined to have prostate cancer
primarily based on PSA, a cancer factor in blood. However, as
diagnostic accuracy is as low as 30%, a considerable number of
patients undergo additional invasive biopsy and thus suffer from
resultant side effects, such as bleeding and pain.